10-Q Filing

HealthLynked Corp CIK: 1680139 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001213900-22-027072`
Period End Date	20220331
Filing Date	20220516
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	f10q0322_healthlynked_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 52 Cash Flow Statement 66 Stockholders Equity 21

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$3.29M	USD	Point-in-time
Cash	`Cash`	$1.93M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of March 31, 2022 and December 31, 2021, respectively	`AccountsReceivableNetCurrent`	$78.13K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of March 31, 2022 and December 31, 2021, respectively	`AccountsReceivableNetCurrent`	$86.29K	USD	Point-in-time
Inventory	`InventoryNet`	$134.93K	USD	Point-in-time
Inventory	`InventoryNet`	$155.15K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$137.63K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$85.69K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$2.25M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$3.65M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $308,480 and $283,512 as of March 31, 2022 and December 31, 2021, respectively	`PropertyPlantAndEquipmentNet`	$347.53K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$308.48K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $308,480 and $283,512 as of March 31, 2022 and December 31, 2021, respectively	`PropertyPlantAndEquipmentNet`	$350.48K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$283.51K	USD	Point-in-time
Intangible assets, net of accumulated amortization (in Dollars)	`DebtInstrumentUnamortizedDiscountCurrent`	$873.42K	USD	Point-in-time
Intangible assets, net of accumulated amortization of $1,052,338 and $873,417 as of March 31, 2022 and December 31, 2021, respectively	`OtherIntangibleAssetsNet`	$4.70M	USD	Point-in-time
Intangible assets, net of accumulated amortization of $1,052,338 and $873,417 as of March 31, 2022 and December 31, 2021, respectively	`OtherIntangibleAssetsNet`	$4.88M	USD	Point-in-time
Intangible assets, net of accumulated amortization (in Dollars)	`DebtInstrumentUnamortizedDiscountCurrent`	$1.05M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Goodwill	`Goodwill`	$1.15M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Goodwill	`Goodwill`	$1.15M	USD	Point-in-time
Right of use lease assets	`LeaseAssetsNonCurrent`	$526.73K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Right of use lease assets	`LeaseAssetsNonCurrent`	$499.14K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	237.89M	shares	Point-in-time
Deferred equity compensation and deposits	`DeferredEquityCompensationAndDeposit`	$138.62K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	238.03M	shares	Point-in-time
Deferred equity compensation and deposits	`DeferredEquityCompensationAndDeposit`	$130.19K	USD	Point-in-time
Total Assets	`Assets`	$9.07M	USD	Point-in-time
Total Assets	`Assets`	$10.69M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	238.03M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	237.89M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$760.39K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$790.84K	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$72.84K	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$33.35K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$288.97K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$294.44K	USD	Point-in-time
Common stock issuable, par value (in Dollars per share)	`CommonStockParValue`	$0.00	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$300.60K	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$300.60K	USD	Point-in-time
Common stock issuable, par value (in Dollars per share)	`CommonStockParValue`	$0.00	USD	Point-in-time
Liability-classified equity instruments, current portion	`DerivativeLiabilitiesCurrent`	$35.62K	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	719,366.00	shares	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	938,191.00	shares	Point-in-time
Liability-classified equity instruments, current portion	`DerivativeLiabilitiesCurrent`	$61.25K	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$403.47K	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$317.76K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.74M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.92M	USD	Point-in-time
Government and vendor notes payable, long term portion	`GovernmentAndVendorNotesPayableLongTermPortion`	$450.00K	USD	Point-in-time
Government and vendor notes payable, long term portion	`GovernmentAndVendorNotesPayableLongTermPortion`	$450.00K	USD	Point-in-time
Liability-classified equity instruments, long term portion	`LongTermDebtNoncurrent`	$101.25K	USD	Point-in-time
Liability-classified equity instruments, long term portion	`LongTermDebtNoncurrent`	$101.25K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$782.22K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$429.61K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$239.22K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$204.76K	USD	Point-in-time
Total Liabilities	`Liabilities`	$2.93M	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.49M	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 238,033,117 and 237,893,473 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$23.79K	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 238,033,117 and 237,893,473 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	`CommonStockValue`	$23.80K	USD	Point-in-time
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and 2,750,000 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	`PreferredStockValue`	$2.75K	USD	Point-in-time
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and 2,750,000 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively	`PreferredStockValue`	$2.75K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 938,191 and 719,366 shares as of March 31, 2022 and December 31, 2021, respectively	`CommonStockIssuableValue`	$282.35K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 938,191 and 719,366 shares as of March 31, 2022 and December 31, 2021, respectively	`CommonStockIssuableValue`	$318.04K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$39.10M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$39.17M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-32.21M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-33.37M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$7.20M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$6.14M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$6.17M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$1.35M	USD	Point-in-time
Total Liabilities and Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$9.07M	USD	Point-in-time
Total Liabilities and Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$10.69M	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.51M	USD	1 Quarter
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.38M	USD	1 Quarter
Subscription, consulting and event revenue	`ConsultingAndEventRevenue`	$84.22K	USD	1 Quarter
Subscription, consulting and event revenue	`ConsultingAndEventRevenue`	$87.66K	USD	1 Quarter
Product revenue	`ProductRevenue`	$182.66K	USD	1 Quarter
Product revenue	`ProductRevenue`	$146.97K	USD	1 Quarter
Total revenue	`Revenues`	$1.61M	USD	1 Quarter
Total revenue	`Revenues`	$1.78M	USD	1 Quarter
Practice salaries and benefits	`LaborAndRelatedExpense`	$718.07K	USD	1 Quarter
Practice salaries and benefits	`LaborAndRelatedExpense`	$663.94K	USD	1 Quarter
Other practice operating expenses	`OperatingCostsAndExpenses`	$562.65K	USD	1 Quarter
Other practice operating expenses	`OperatingCostsAndExpenses`	$730.78K	USD	1 Quarter
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$227.73K	USD	1 Quarter
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$211.51K	USD	1 Quarter
Cost of product revenue	`CostOfRevenues`	$168.60K	USD	1 Quarter
Cost of product revenue	`CostOfRevenues`	$160.81K	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.34M	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.37M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$211.66K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$203.89K	USD	1 Quarter
Total Operating Expenses and Costs	`OperatingExpenses`	$3.35M	USD	1 Quarter
Total Operating Expenses and Costs	`OperatingExpenses`	$3.21M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.57M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.60M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-5.59M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-19.25K	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	1 Quarter
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$-635.70K	USD	1 Quarter
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$438.32K	USD	1 Quarter
Interest expense	`InterestIncomeexpense`	$5.02K	USD	1 Quarter
Interest expense	`InterestIncomeexpense`	$10.59K	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$433.30K	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$-6.26M	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-7.82M	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.17M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.17M	USD	1 Quarter
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$88.39K	USD	1 Quarter
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$88.39K	USD	1 Quarter
Net loss to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.26M	USD	1 Quarter
Net loss to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-7.91M	USD	1 Quarter
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.04	USD	1 Quarter
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.04	USD	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	238.01M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	213.28M	shares	1 Quarter
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	238.01M	shares	1 Quarter
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	213.28M	shares	1 Quarter

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-7.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.17M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$211.66K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$203.89K	USD	1 Quarter
Stock based compensation, including amortization of deferred equity compensation	`EmployeeBenefitsAndShareBasedCompensation`	$116.73K	USD	1 Quarter
Stock based compensation, including amortization of deferred equity compensation	`EmployeeBenefitsAndShareBasedCompensation`	$307.16K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-5.59M	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Change in fair value of debt	`NoncashExpense`	$19.25K	USD	1 Quarter
Change in fair value of debt	`NoncashExpense`	-	USD	1 Quarter
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	$438.32K	USD	1 Quarter
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	$-635.70K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$38.15K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-8.16K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$16.20K	USD	1 Quarter
Inventory	`IncreaseDecreaseInInventories`	$20.22K	USD	1 Quarter
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-4.03K	USD	1 Quarter
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-26.31K	USD	1 Quarter
ROU lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$33.31K	USD	1 Quarter
ROU lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$24.23K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-83.85K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-30.45K	USD	1 Quarter
Lease liability	`IncreaseDecreaseInLeaseLiability`	$24.96K	USD	1 Quarter
Lease liability	`IncreaseDecreaseInLeaseLiability`	$34.71K	USD	1 Quarter
Contract liabilities	`IncreaseDecreaseInDeferredRevenue`	$-22.37K	USD	1 Quarter
Contract liabilities	`IncreaseDecreaseInDeferredRevenue`	$-39.49K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.34M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.22M	USD	1 Quarter
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.01K	USD	1 Quarter
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.40K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-7.40K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-22.01K	USD	1 Quarter
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$4.39M	USD	1 Quarter
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from exercise of options and warrants	`ProceedsFromExerciseOfOptionsAndWarrants`	$65.65K	USD	1 Quarter
Proceeds from exercise of options and warrants	`ProceedsFromExerciseOfOptionsAndWarrants`	-	USD	1 Quarter
Repayment of vendor loans payable	`RepaymentsOfNotesPayable`	$51.11K	USD	1 Quarter
Repayment of vendor loans payable	`RepaymentsOfNotesPayable`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.40M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$3.18M	USD	1 Quarter
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.36M	USD	1 Quarter
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.93M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.34M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$162.18K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.93M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.34M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$162.18K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$232.00	USD	1 Quarter
Cash paid during the period for interest	`InterestPaidNet`	-	USD	1 Quarter
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	1 Quarter
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	1 Quarter
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$37.78K	USD	1 Quarter
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$66.16K	USD	1 Quarter
Incremental fair value of warrants modified to extend maturity date of convertible notes payable	`IncrementalFairValueOfWarrantsModifiedToExtendMaturityDateOfConvertibleNotesPayable`	$126.50K	USD	Point-in-time
Incremental fair value of warrants modified to extend maturity date of convertible notes payable	`IncrementalFairValueOfWarrantsModifiedToExtendMaturityDateOfConvertibleNotesPayable`	-	USD	Point-in-time
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$4.06M	USD	1 Quarter
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	-	USD	1 Quarter
Fair value of warrants issued in connection with conversion of convertible notes payable	`FairValueOfWarrantsIssuedInConnectionWithConversionOfConvertibleNotesPayable`	$3.07M	USD	Point-in-time
Fair value of warrants issued in connection with conversion of convertible notes payable	`FairValueOfWarrantsIssuedInConnectionWithConversionOfConvertibleNotesPayable`	-	USD	Point-in-time
Accrued liabilities relieved upon cashless exercise of warrants	`AccruedLiabilitiesRelievedUponCashlessExerciseOfWarrants`	$614.22K	USD	1 Quarter
Accrued liabilities relieved upon cashless exercise of warrants	`AccruedLiabilitiesRelievedUponCashlessExerciseOfWarrants`	-	USD	1 Quarter
Fair value of liability-classified equity instruments cancelled (net of earned)	`FairValueOfMarketableSecuritiesReceived`	$25.62K	USD	1 Quarter
Fair value of liability-classified equity instruments cancelled (net of earned)	`FairValueOfMarketableSecuritiesReceived`	-	USD	1 Quarter

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$7.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.17M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.35M	USD	Point-in-time
Sales of common stock	`SaleOfCommonAndPreferredStockInExchangeForMarketableSecurities`	$2.98M	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockIssuedDuringPeriodValueOther`	$1.41M	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$4.06M	USD	1 Quarter
Fair value of warrants issued in connection with conversion and retirement of convertible notes payable	`FairValueOfWarrantsIssuedAndModifiedInConnectionWithConversionAndRetirementOfConve`	$3.20M	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$32.43K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$81.52K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$237.33K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan`	$37.41K	USD	1 Quarter
Exercise of stock warrants	`Exerciseofwarrants`	$676.72K	USD	1 Quarter
Shares and options issued to employees	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$26.78K	USD	1 Quarter
Exercise of stock options	`ExerciseOfStockOptionsValue`	$3.15K	USD	1 Quarter
Net loss	`ProfitLoss`	$-7.82M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.17M	USD	1 Quarter
Balance	`StockholdersEquity`	$7.20M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.14M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.17M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.35M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.